5 Top Penny Stocks

Penny stocks, often priced below $5 per share, can be an intriguing avenue for investors seeking high returns. In this article, we leverage insights from the TipRanks Penny Stock Screener to bring you five top penny stocks in the United States. These stocks not only have received a Strong buy rating but also boast impressive Smart Scores, indicating their potential to outperform the market.

5 Best NASDAQ Penny Stocks To Invest In


Emcore, a provider of mixed-signal optics products, plays a crucial role in high-speed communication networks and defense systems. The stock’s average price target suggests an impressive 419.2% upside potential, complemented by a Smart Score of eight, making EMKR an exciting prospect in the penny stock arena.


Asure specializes in human capital management software and services, making it a key player in an ever-evolving industry. ASUR’s average price target of $14.43 implies a substantial 74.5% upside potential, supported by a Smart Score of nine, highlighting its promising position in the market.

Humacyte (NASDAQ:HUMA)

A biotechnology company focusing on regenerative medicine, Humacyte, stands out with an analyst consensus upside of 170.3%. With a Smart Score of eight, HUMA presents an intriguing opportunity for investors interested in the intersection of biotechnology and regenerative medicine.

Syros Pharmaceuticals (NASDAQ:SYRS)

Syros Pharmaceuticals focuses on developing gene-control therapies for cancer and genetic diseases. With an average price target suggesting a remarkable 201.7% upside potential, SYRS stands out as a top pick. The stock’s Smart Score of “Perfect 10” further reinforces its promising outlook.

Gritstone Oncology (NASDAQ:GRTS)

Specializing in personalized cancer immunotherapies, Gritstone Oncology has a price forecast indicating a substantial 265% upside potential. Boasting an outperforming Smart Score of eight, GRTS presents a compelling opportunity for investors looking to capitalize on advancements in biotechnology.

magnifying glass on top of document
Penny Stocks Analysis

Read more: – Top 5 Tata Penny Stocks to Watch

Frequently Asked Questions (FAQs)

  1. Are penny stocks a reliable investment?
    • While penny stocks offer potential for high returns, they come with higher risks. Thorough research and a diversified approach are essential for mitigating these risks.
  2. How is the Smart Score determined for these stocks?
    • The Smart Score is based on various factors, including analyst ratings, price targets, and market trends, providing a comprehensive assessment of a stock’s potential.
  3. What does a “Strong buy” rating from analysts indicate?
    • A “Strong buy” rating suggests a high level of confidence among analysts in the stock’s potential for future growth.
  4. Can these penny stocks be considered for long-term investments?
    • While some penny stocks may present long-term opportunities, investors should stay informed and continually assess their investments due to the inherent volatility.
  5. How reliable are price targets for penny stocks?
    • Price targets are projections based on analysts’ assessments. However, market conditions can change, so it’s crucial to monitor the stocks regularly for any updates or shifts.
  6. Are there risks associated with investing in biopharmaceutical penny stocks like Syros Pharmaceuticals and Humacyte?
    • Yes, investing in biopharmaceutical penny stocks carries risks related to clinical trial outcomes, regulatory approvals, and market dynamics. Investors should be aware of these factors.


Exploring penny stocks requires diligence and a well-informed strategy. The highlighted stocks—Emcore, Asure, Humacyte, Syros Pharmaceuticals, and Gritstone Oncology—offer potential opportunities for investors seeking high returns. However, it’s crucial to conduct thorough research, stay informed, and approach penny stock investments with caution.

5 replies on “5 Top Penny Stocks in the United States (2024)”

Comments are closed.